Resting muscle sympathetic nerve activity, cardiac metaiodobenzylguanidine uptake, and exercise tolerance in patients with left ventricular dysfunction

Journal of Nuclear Cardiology

Volumn 16, Issue 2, 2009, Pages 244-250

  Yoh, Masue ^a   Yuasa, Fumio ^a   Mimura, Jun ^a   Yokoe, Hiroshi ^a   Kawamura, Akihiro ^a   Sugiura, Tetsuro ^b   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Exercise tolerance; Heart failure; Oxygen consumption; Sympathetic nerve activity

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; IODINE; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXERCISE TOLERANCE; FEMALE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE; HEART SCINTISCANNING; HUMAN; MALE; NEUROGRAPHY; PRIORITY JOURNAL; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; HEART LEFT VENTRICLE FUNCTION; INNERVATION; MIDDLE AGED; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; SCINTISCANNING; SKELETAL MUSCLE;

3-IODOBENZYLGUANIDINE; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SKELETAL; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67649975972     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-008-9039-8     Document Type: Article

References (29)

1. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995;92:3206-11.
2. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986;73:913-9.
3. Smith RF, Johnson G, Ziesche S, Bhat G, Blankenship K, Cohn JN. Functional capacity in heart failure: Comparison of methods for assessment and their relation to other indexes of heart failure. Circulation 1993;87:VI-88-93
4. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986;73:615-21.
5. Ferguson DW, Berg WJ, Sanders JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: Evidence from direct microneurographic recordings. J Am Coll Cardiol 1990;16:1125-34.
6. Levine TB, Francis GS, Goldsmith SR, Simon A, Cohn JN. Activity of the sympathetic nervous system and renin angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982;49:1659-66.
7. Chidsey CA, Harrison DC, Braunwald E. Augmentation of the plasma norepinephrine response to exercise in patients with congestive heart failure. N Eng J Med 1962;267:650-4.
8. Zelis R, Nellis SH, Longhurst J, Lee G, Mason DT. Abnormalities in the regional circulation accompanying congestive heart failure. Prog Cardiovasc Dis 1975;28:181-99.
9. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler M. Cardiac sympathetic nervous activity in congestive heart failure: Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 1993;88:136-45.
10. Kaye DM, Lambert GW, Dewar EM, Jennings GL, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 1994;23:570-8.
11. Rundqvist B, Elam M, Sverrisdottri YB, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997;95:169-75.
12. Delius W, Hagbarth KE, Hongell A, Wallin BG. Manoeuvres affecting sympathetic outflow in human muscle nerves. Acta Physiol Scand 1972;84:82-94.
13. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, et al. Myocardial imaging in man with Iodine-123 metaiodobenzylguanidine. J Nucl Med 1981;22:129-32.
14. Schofer J, Spielmann R, Schuchert A, Weber K, Schilder M. Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988;12:1252-8.
15. Sisson J, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland DM, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987;28:1625-36.
16. Francis GS, Goldsmith SR, Cohn JN. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J 1982;4:725-31.
17. Lang CC, Rayos GH, Chomsky DB, Wood AJJ, Wilson JR. Effect of sympathoinhibition on exercise performance in patients with heart failure. Circulation 1997;96:238-45.
18. Notarius CF, Ando S, Rongen GA, Floras JS. Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects. Eur Heart J 1999;20:880-7.
19. Notarius CF, Azevedo ER, Parker JD, Floras JS. Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure. Eur Heart J 2002;23:800-5.
20. Mark AL, Victor RG, Nerhed C, Wallin BG. Micronurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Cir Res 1985;57:461-9.
21. Atsumi H, Takeishi Y, Fujiwara S, Tomoike H. Cardiac sympathetic nervous disintegrity is related to exercise intolerance in patients with chronic heart failure. Nucl Med Comm 1988;19:451-6.
22. Cohen-Solal A, Esanu Y, Logeart D, Pessione F, Dubois C, Dreyfus G, et al. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: Relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 1999;33:759-66.
23. Estorch M, Flotats A, Grima RS, Mari C, Prat T, Martin JC, et al. Influence of exercise rehabilitation on myocardial perfusion and sympathetic heart innervation in ischaemic heart disease. Eur J Nucl Med 2000;27:333-9.
24. Sinoway L, Prophet S. Skeletal muscle metaboreceptor stimulation opposes peak metabolic vasodilation in humans. Cir Res 1990;66:1576-84.
25. Richter EA, Ruderman NB, Galbo H. Alpha and beta adrenergic effects on metabolism in contracting, perfused muscle. Acta Physiol Scand 1982;116:215-22.
26. Stainsby WN, Summers C, Eitzman PD. Effects of catecholamines on lactic acid output during progressive working contractions. J Appl Physiol 1985;59:1809-14.
27. Franciosa JA, Leddy CL, Wilen M, Schwartz DE. Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. Am J Cardiol 1984;53:127-34.
28. Sullivan MJ, Knight D, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Circulation 1989;80:769-81.
29. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: Role of impaired nutritive flow to skeletal muscle. Circulation 1984;69:1079-87.